Prostatectomy

Researchers at Keck Medicine of USC are part of a national, multisite clinical trial to evaluate a minimally invasive water vapor system that uses steam to treat prostate cancer.

Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.

An AI model revealed tumor size to be an independent factor when determining risk for prostate cancer recurrence or metastasis, according to results of a retrospective study.

A blood test for men at the time of a metastatic prostate cancer diagnosis may predict treatment response and survival, according to study results.

Olaparib monotherapy may be an effective treatment option for certain men with biochemically recurrent prostate cancer, according to results of a nonrandomized phase 2 trial.

The American Urological Association released a clinical practice guideline pertaining to salvage therapy for men with prostate cancer.

Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.

Men with localized prostate cancer exhibited low risk for disease-specific mortality regardless of their assigned treatment, according to study results published in The New England Journal of Medicine.

Long-course androgen depravation therapy extended metastasis-free survival compared with short-course ADT when added to radiotherapy after radical prostatectomy, results of the randomized phase 3 RADICALS-HD trial showed.

Smilow Cancer Hospital has introduced a new single-port robotic prostatectomy procedure that reduces the number of incisions and may minimize the risk for complications.